|Articles|July 28, 2023
NeurologyLive® Friday 5 — July 28, 2023
Author(s)NeurologyLive® Staff
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 28, 2023.
Advertisement
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Roundtable: Building a Greater Understanding for Dravet Syndrome
A duo of experts provide insight on various topics related to the advances in treatment options, diagnosis of the disorder, role of genetics, and potential future research and gene therapies.
2: Peer Exchange: Concluding Thoughts on Biosimilars in Multiple Sclerosis
In episode 11 of the "How Similar are Biosimilars? A look into the Future with Biosimilars in Multiple Sclerosis" Peer Exchange series, Amy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.
3: NeuroVoices: Alessio Travaglia, PhD, on Utilizing Available Alzheimer Biomarkers Properly
In the latest edition of our in-depth Q&A series, the director at the Foundation for the National Institutes of Health provided perspective on the effective ways to utilize currently available biomarkers for Alzheimer disease research.
4: Neurology News Network: The Safety of Other S1P Receptor Modulators in Multiple Sclerosis
Krzysztof Selmaj, MD, PhD, presents the key results on the safety of other sphinogine-1-phospate (S1P) receptor modulators, such as fingolimod and ponesimod, in the treatment of multiple sclerosis (MS).
5: Advancing Research With Remote Blood Collection for Alzheimer Biomarkers: Hanna Huber, PhD
The researcher in the department of neurochemistry at the University of Gothenburg in Sweden discussed bloodspot cards as a promising method for collecting blood samples in Alzheimer disease research. [WATCH TIME: 4 minutes]
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
2
NeurologyLive® Friday 5 — September 12, 2025
3
Expanding the Alzheimer Drug Development Pipeline
4
Patient-Reported Study Identifies Common Symptoms and Timing During Migraine Prodrome
5